Androgenetic Alopecia Treatment Market Segments, Drivers, Restraints, And Trends For 2024-2033

July 25, 2024 10:31 PM AEST | By EIN Presswire
 Androgenetic Alopecia Treatment Market Segments, Drivers, Restraints, And Trends For 2024-2033
Image source: EIN Presswire

LONDON, GREATER LONDON , UK, July 25, 2024 /EINPresswire.com/ -- The androgenetic alopecia treatment market has experienced robust growth in recent years, expanding from $2.13 billion in 2023 to $2.29 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to emphasis on improving patient outcomes and quality of life, increase in the geriatric population, increasing healthcare expenditure.

Strong Future Growth Anticipated
The androgenetic alopecia treatment market is projected to continue its strong growth, reaching $3.07 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to rising incidence of hair loss, prevalence of chronic diseases such as cancer, polycystic ovary syndrome (PCOS), and rheumatoid arthritis, demand for effective solutions to address hair loss concerns.

Explore Comprehensive Insights Into The Global Androgenetic Alopecia Treatment Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=15721&type=smp

Growth Driver Of The Androgenetic Alopecia Treatment Market
The rising hair loss cases are expected to propel the growth of the androgenetic alopecia treatment market going forward. Hair loss or alopecia refers to the partial or complete loss of hair from the scalp or other body parts. Hair loss cases are related to nutritional deficiencies, hormonal changes, genetics, and increased stress. Androgenetic alopecia treatments work through various mechanisms, including hormonal regulation, follicle stimulation, and surgical restoration, to manage hair loss and promote regrowth.

Order Your Report Now For Swift Delivery:
https://www.thebusinessresearchcompany.com/report/androgenetic-alopecia-treatment-global-market-report

Androgenetic Alopecia Treatment Market Major Players And Market Trends
Key players in the androgenetic alopecia treatment market include Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eli Lilly and Company, Daiichi-Sankyo Co. Ltd.

Major companies operating in the androgenetic alopecia treatment market are developing innovative drug options for addressing hair loss through mechanisms such as promoting hair follicle regeneration, inhibiting hormones that cause hair loss, and using novel delivery systems like topical treatments and oral medications.

Androgenetic Alopecia Treatment Market Segments:
1) By Treatment Type: Pharmaceutical, Device
2) By Medication Type: Prescription, Over-The-Counter
3) By Gender: Male, Female
4) By End-User: Homecare Settings, Dermatology, Clinics, Other End-Users

Geographical Insights: North America Leading The Market
North America was the largest region in the androgenetic alopecia treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the androgenetic alopecia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Androgenetic Alopecia Treatment Market Definition
Androgenetic alopecia, also known as male-pattern baldness or female-pattern hair loss, is a common form of hair loss in both men and women. It is characterized by a progressive thinning of the hair, typically starting with a receding hairline in men and diffuse thinning over the crown in women. This condition is influenced by genetic factors and the presence of androgens, particularly dihydrotestosterone (DHT).

Androgenetic Alopecia Treatment Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Androgenetic Alopecia Treatment Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on androgenetic alopecia treatment market size, androgenetic alopecia treatment market drivers and trends, androgenetic alopecia treatment market major players, androgenetic alopecia treatment competitors' revenues, androgenetic alopecia treatment market positioning, and androgenetic alopecia treatment market growth across geographies. The androgenetic alopecia treatment market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Alopecia Areata Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/alopecia-areata-global-market-report

Alopecia Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/alopecia-global-market-report

Fertility Treatments Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.